These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2457083)

  • 1. Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties.
    Hamon M; Fattaccini CM; Adrien J; Gallissot MC; Martin P; Gozlan H
    J Pharmacol Exp Ther; 1988 Aug; 246(2):745-52. PubMed ID: 2457083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
    Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
    Jolas T; Haj-Dahmane S; Kidd EJ; Langlois X; Lanfumey L; Fattaccini CM; Vantalon V; Laporte AM; Adrien J; Gozlan H
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1432-43. PubMed ID: 8138956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of acute and chronic treatment of rats with the putative anxiolytic drug ipsapirone on the turnover of monoamine transmitters in various brain regions. A comparison with the 5-HT1A agonist 8-OH-DPAT.
    Gołembiowska K
    Pol J Pharmacol Pharm; 1992; 44(1):15-24. PubMed ID: 1359515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?
    Jolas T; Schreiber R; Laporte AM; Chastanet M; De Vry J; Glaser T; Adrien J; Hamon M
    J Pharmacol Exp Ther; 1995 Feb; 272(2):920-9. PubMed ID: 7853210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
    Kidd EJ; Haj-Dahmane S; Jolas T; Lanfumey L; Fattaccini CM; Guardiola-Lemaitre B; Gozlan H; Hamon M
    J Pharmacol Exp Ther; 1993 Feb; 264(2):863-72. PubMed ID: 8094756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and electrophysiological evidence for an agonist action of CM 57493 at pre- and postsynaptic 5-hydroxytryptamine1A receptors in brain.
    Adrien J; Lanfumey L; Gozlan H; Fattaccini CM; Hamon M
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1222-30. PubMed ID: 2522986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via 5-hydroxytryptamine1A receptors: A comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635.
    de Boer SF; Lesourd M; Mocaer E; Koolhaas JM
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1125-33. PubMed ID: 10027850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of 5-HT1A receptor binding sites following chronic treatment with ipsapirone measured by quantitative autoradiography.
    Fanelli RJ; McMonagle-Strucko K
    Synapse; 1992 Sep; 12(1):75-81. PubMed ID: 1357765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ipsapirone, a new anxiolytic drug, stimulates catecholamine turnover in various regions of the rat brain.
    Gołembiowska K
    Pol J Pharmacol Pharm; 1990; 42(2):143-50. PubMed ID: 1980361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
    Schreiber R; De Vry J
    Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in rats.
    Gobert A; Lejeune F; Rivet JM; Audinot V; Newman-Tancredi A; Millan MJ
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1032-46. PubMed ID: 7791073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain.
    Blier P; de Montigny C
    Synapse; 1987; 1(5):470-80. PubMed ID: 2905533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excitation of noradrenergic cell firing by 5-hydroxytryptamine1A agonists correlates with dopamine antagonist properties.
    Piercey MF; Smith MW; Lum-Ragan JT
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1297-303. PubMed ID: 8138943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement by ipsapirone of dopamine release in the rat striatum.
    Gołembiowska K; Wedzony K
    Pol J Pharmacol; 1993; 45(3):299-308. PubMed ID: 7693136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The presynaptic metabolic modulation of the impulse-dependent release of 3H-serotonin from rat brain slices by ipsapirone (TVX Q 7821) and other serotonin agonists].
    Dolzhenko AT; Traber J; Glaser T; De Vry J
    Eksp Klin Farmakol; 1993; 56(4):9-12. PubMed ID: 8106062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of buspirone and its metabolite, 1-(2-pyrimidinyl)piperazine, on brain monoamines and their metabolites in rats.
    Fuller RW; Perry KW
    J Pharmacol Exp Ther; 1989 Jan; 248(1):50-6. PubMed ID: 2521515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ipsapirone on the level of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in some regions of the rat brain.
    Gołembiowska K
    Pol J Pharmacol Pharm; 1989; 41(1):33-9. PubMed ID: 2479937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.